Össur hf (CPH:OSSR) reported on Monday that under its share buy back programme, it has acquired 853,424 shares at the average price of DKK51.59.
The company said that on 26 November 2019, it initiated a share buy-back programme, the purpose of which is to reduce the company's share capital and adjust the capital structure by distributing capital to shareholders in line with the company's capital structure and dividend policy.
This programme will end no later than 11 March 2020. The company may purchase up to 5,000,000 shares under the programme, corresponding to 1.2% of the current share capital. The total consideration for shares purchased under the programme shall not exceed USD10m.
Following this repurchase, Össur's holding of own shares is 3,809,635 corresponding to 0.90% of the company's total share capital.
Össur provides non-invasive orthopaedics and is focused on improving people's mobility through the delivery of innovative technologies within the fields of prosthetics and bracing and supports.
(EUR1.00=DKK7.47)
Eli Lilly announces Q1 2026 dividend
Amgen announces Q4 2025 dividend
Bavarian Nordic secures new EU contract for up to 8 million smallpox and mpox vaccine doses
Thermo Fisher Scientific to acquire Clario Holdings, expanding clinical data capabilities
Nanoform and Revio Therapeutics partner to develop long-acting hydrogel therapy for glioma
Cumberland Pharmaceuticals adds FDA-approved oral capsule for H. pylori to commercial portfolio
IP Group positions for future royalties following Pfizer's USD7.3bn acquisition of Metsera
AstraZeneca strikes landmark drug pricing deal with US Government